Walker v. Pharmaceutical Research Manufacturers of America

CourtDistrict Court, District of Columbia
DecidedMarch 10, 2009
DocketCivil Action No. 2004-1991
StatusPublished

This text of Walker v. Pharmaceutical Research Manufacturers of America (Walker v. Pharmaceutical Research Manufacturers of America) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walker v. Pharmaceutical Research Manufacturers of America, (D.D.C. 2009).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

BARBARA J. WALKER, : : Plaintiff, : Civil Action No.: 04-1991 (RMU) : v. : Document No.: 98 : PHARMACEUTICAL RESEARCH AND : MANUFACTURERS OF AMERICA et al., : : Defendants. :

MEMORANDUM OPINION

GRANTING THE PLAINTIFF’S MOTION FOR LEAVE TO FILE A SECOND AMENDED COMPLAINT

I. INTRODUCTION

After years of battling, the plaintiff requests that the court grant her leave to file a second

amended complaint to clarify her claims, which stem from alleged violations of the Employee

Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. §§ 1001 et seq. The remaining

defendants, current or former members of the board of directors of Pharmaceutical Research and

Manufacturers of America 1 (“PhRMA”) and members of the PhRMA retirement committee

(collectively the “individual defendants”), as well as the New York Life Insurance Company

(“NYLIC”) and New York Life Investment Management, Inc. (“NYLIM”) (collectively the

“NYL defendants”), oppose the plaintiff’s motion, viewing it as a futile attempt to expand the

battlefield. Because the plaintiff’s proposed second amended complaint does not add any claims

not previously asserted in her first amended complaint, the court grants the plaintiff’s motion.

1 At the time the plaintiff began her employment with the defendant, the association was known as the Pharmaceutical Manufacturers Association (“PMA”). II. BACKGROUND

A. Factual Background

The plaintiff, an attorney, was a full-time employee of PhRMA in various professional

capacities from 1977 to 1988. Mem. Op. (July 17, 2006) at 2. Following the birth of her second

child in 1988, the plaintiff requested but was denied a part-time work arrangement because

PhRMA’s then-president “did not believe in part-time professionals.” Id. Instead, PhRMA’s

General Counsel, Bruce Brennan, suggested that the plaintiff serve as an independent contractor.

Id. The plaintiff accepted this arrangement and signed an independent contractor agreement on

March 24, 1988. 2 Id. At the expiration of that agreement, the plaintiff and PhRMA signed

identically worded agreements every year until 2001. Id. at 3. The final agreement, signed on

September 12, 2001, notified the plaintiff that PhRMA did not intend to continue their

relationship following the expiration of the agreement on June 30, 2002. Id.

The independent contractor agreements signed by the plaintiff each year stated that the

plaintiff “shall be engaged as an independent contractor, not as an employee, and shall not be

entitled to participate in any of [PhRMA’s] employee benefit plans.” Id. at 2-3. The plaintiff

alleges that she signed the independent contractor agreements based on the belief that part-time

employees, like independent contractors, were ineligible for employee benefits. Id. at 2. In other

words, the plaintiff alleges that she “had no reason” to challenge her classification as an

independent contractor rather than as a part-time employee because she believed the “terms and

conditions of her employment” were the same as those of part-time employees. Pls.’ Mot. to

Alter or Amend J. at 5.

2 On March 28, 1988, the plaintiff submitted her resignation, effective April 17, 1988. PhRMA Defs.’ Mot. for Summ. J. at 2. The independent contractor agreement became effective April 18, 1988. Id.

2 Sometime between 1991 and 1994, PhRMA reinterpreted its retirement plan to make

part-time employees eligible for certain retirement benefits. Id. at 5. The plaintiff alleges that

the defendants violated ERISA by failing to notify independent contractors of the changes

affecting part-time employees and failing to provide plan documents. Id. at 5, 13, 16; Am.

Compl. ¶ 71.

B. Procedural Background

The plaintiff filed her original complaint on November 11, 2004, and she amended her

complaint in August 2005. Although difficult to parse, the amended complaint appears to assert

the following claims arising under ERISA 3 : (1) that the plaintiff is entitled to benefits under 29

U.S.C. § 1132(a)(1) (“ERISA § 502”); (2) that the defendants interfered with her right to

retirement benefits by improperly classifying her as an independent contractor in violation of 29

U.S.C. § 1140 (“ERISA § 510”); and (3) that the defendants breached their fiduciary duties by

either failing to notify the plaintiff that part-time employees were eligible to receive benefits or

by classifying her as an independent contractor, rather than as a part-time employee, in violation

of 29 U.S.C. § 1104 (“ERISA § 404”).

The PhRMA defendants 4 moved for summary judgment in October 2005 on the grounds

that the statute of limitations bars the plaintiff’s ERISA claims and that ERISA preempts the

plaintiff’s common law claims. See generally PhRMA’s Mot. for Summ. J. The court granted

the PhRMA defendants’ motion on July 17, 2006, determining that (1) the three-year statute of

limitations bars the plaintiff’s § 502 claim; (2) applying either a one-year or a three-year statute

3 Because the plaintiff’s complaint does not list her claims as separate counts, see generally Pl.’s Am. Compl., the court relies on the defendants’ characterization of the claims, see Defs.’ Mot. for Summ. J. at 3. The plaintiff has not disputed this characterization of her claims. See generally Pl.’s Mot. (referring to the ERISA § 502 and ERISA § 404 claims). 4 These defendants include PhRMA, PhRMA Retirement Plan, PhRMA Savings Plan and PhRMA Committee. PhRMA Defs.’ Mot. for Summ. J.

3 of limitation would bar the plaintiff’s § 510 claim; (3) the statute of limitations bars the

plaintiff’s § 404 claim because the plaintiff had knowledge of the alleged breach or violation

more than three years before she filed suit; and (4) ERISA preempts the plaintiff’s D.C. common

law claims. See generally Mem. Op. (July 17, 2006). The plaintiff then filed a motion to alter or

amend judgment on July 31, 2006. But the court denied the plaintiff’s motion, reaffirming the

dismissal of each of the plaintiff’s claims. Mem. Op. (Nov. 15, 2006).

The remaining defendants – the individual defendants and the NYL defendants – then

filed motions to dismiss and for summary judgment. The plaintiff brings the same claims against

these defendants that she brought against the PhRMA defendants. On August 7, 2008, the court

issued a memorandum opinion clarifying that the reasoning rejecting the plaintiff’s § 404 claim

“applies equally to the claims against the remaining defendants to the extent that they rely on the

misclassification of the plaintiff as an independent contractor or the withholding of information

pertaining to part-time employees’ eligibility status.” Mem. Op. (Aug. 7, 2008) at 11-12. To the

extent her § 404 claim alleges that the defendants failed to provide plan information, the court

denied the New York Life defendants’ motion for summary judgment because discovery was not

yet complete and the record was insufficient to make a decision as a matter of law. Id. at 12-14.

As to the individual defendants, the court granted in part their motion to dismiss claims arising

prior to November 15, 1998, because the statute of limitations had run. Id. at15.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Harrison, Sepedra v. Rubin, Robert E.
174 F.3d 249 (D.C. Circuit, 1999)
Bowden, Roy E. v. United States
176 F.3d 552 (D.C. Circuit, 1999)
James v. Hurson Associates, Inc. v. Glickman
229 F.3d 277 (D.C. Circuit, 2000)
Stokes, Billy v. Cross, Steven
327 F.3d 1210 (D.C. Circuit, 2003)
United States Information Agency v. Jan Krc
905 F.2d 389 (D.C. Circuit, 1990)
Myrna O'Dell Firestone v. Leonard K. Firestone
76 F.3d 1205 (D.C. Circuit, 1996)
Clark v. Feder Semo & Bard, P.C.
560 F. Supp. 2d 1 (District of Columbia, 2008)
Wiggins v. District Cablevision, Inc.
853 F. Supp. 484 (District of Columbia, 1994)
Robinson v. Detroit News, Inc.
211 F. Supp. 2d 101 (District of Columbia, 2002)
Willoughby v. Potomac Electric Power Co.
100 F.3d 999 (D.C. Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Walker v. Pharmaceutical Research Manufacturers of America, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walker-v-pharmaceutical-research-manufacturers-of-america-dcd-2009.